Breast Cancer Susceptibility Genetic Testing; Where Should Medical Professionals Stand Between Providers and Customers?

Elham Fakhrejahani (1)
(1) Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan, Japon
https://doi.org/10.19187/abc.20174384-86

##plugins.themes.novelty.article.sidebar##

Numéro
Vol 4, No 3: August 2017
Soumise
août 19, 2017
Publié-e
octobre 23, 2017
Mots-clés :
    Genetic testing, medical ethics, breast cancer
PDF (English)

Résumé

NA

##article.full_articles##

##article.generated_from_xml##

Auteurs-es

Elham Fakhrejahani
Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
elham@kuhp.kyoto-u.ac.jp (##journal.primary_contact##)
1.
Fakhrejahani E. Breast Cancer Susceptibility Genetic Testing; Where Should Medical Professionals Stand Between Providers and Customers?. Arch Breast Cancer [Internet]. 23 oct. 2017 [cité 12 janv. 2026];4(3):84-6. Disponible à: https://www.archbreastcancer.com/index.php/abc/article/view/153
Télécharger la référence
Endnote/Zotero/Mendeley (RIS)

(c) Tous droits réservés Archives of Breast Cancer 2017

Licence Creative Commons

Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale 4.0 International.

Copyright©. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International License, which permits copy and redistribution of the material in any medium or format or adapt, remix, transform, and build upon the material for any purpose, except for commercial purposes.

##plugins.themes.novelty.article.details##

Articles similaires

Vous pouvez également Lancer une recherche avancée d’articles similaires à cet article.